Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ABTL-0812 induces endoplasmic reticulum (ER) stress-mediated autophagy, and with anti-cancer activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,200.00 | |
50 mg | 6-8 weeks | $ 1,570.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | ABTL-0812 induces endoplasmic reticulum (ER) stress-mediated autophagy, and with anti-cancer activity. |
In vitro | cell viability of squamous NSCLC H157 cells inhibited by ABTL-0812 (ABTL0812; 10-100 μM; 48 hours). Compared with squamous NSCLC H157 cells, human lung fibroblast cell line MRC-5 are resistant to ABTL0812 treatment. |
In vivo | In human lung and pancreatic xenografts, ABTL-0812 (ABTL0812; 120 mg/kg; oral gavage; 5 times per week; for 33 d) induces ER stress. In vivo, ABTL-0812 induces hallmarks of ER stress . ABTL-0812 increases ATF4 and HSPA5 expression in mice bearing MiaPaca2 and A549 xenograft, respectively. |
Synonyms | α-Hydroxylinoleic acid |
Molecular Weight | 296.44 |
Formula | C18H32O3 |
CAS No. | 57818-44-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ABTL-0812 57818-44-7 Others alpha-Hydroxylinoleic acid α-Hydroxylinoleic acid ABTL 0812 ABTL0812 a-Hydroxylinoleic acid inhibitor inhibit